Subscription Required

Only paid subscribers* to Drug Benefit News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Drug Benefit News receive

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered by First Class U.S. Mail and electronically,
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from your editor.
View a sample and get more information
May 22, 2015

Recent Stories of Interest

From Drug Benefit News - As the big three publicly traded PBMs reported first-quarter 2015 earnings, there was underlying concern about how the pending acquisition of Catamaran Corp. by UnitedHealth Group is likely to shake out during the 2016 selling season and impact the marketplace. Industry observers suggested that Express Scripts and CVS Health may reap the benefits of unrest created by the potential transaction. UnitedHealth Group on March 30 unveiled plans to acquire stand-alone PBM Catamaran and merge it with the health plan operator’s PBM unit OptumRx. Read more

Despite Otsuka Pharmaceutical Co., Ltd.’s best efforts to block any generic version… Read more

Nearly a year after the last of the valid patents on Teva… Read more

After mulling a proposed rule on generic drug labeling for the last… Read more

From the Editor

Welcome to your Drug Benefit News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with comments on the last issue of Drug Benefit News, story ideas for future issues or any other suggestions you have that can make the newsletter more useful for you.

May 21, 2015
CVS Agrees to Acquire Omnicare

CVS Health plans to buy LTC pharmacy services provider Omnicare in a deal worth $12.7 billion.

April 21, 2015
Compounded Drugs Drove Employee Costs in 2014

Compounded medicine once again drove workers' compensation drug costs in 2014, says new Express Scripts report.

April 16, 2015
FDA Approves First Generic Copaxone for MS

The FDA approved Sandoz’s Glatopa, the first generic version of Teva’s multiple sclerosis treatment Copaxone (glatiramer acetate) in a 20 mg/ml once-daily injection

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?